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Abstract
Background: There is a growing interest in the role of the endothelium in migraine. Recently, our group showed
differences in endothelial function between the anterior and posterior cerebral circulation in healthy subjects,
reduced vasodilatatory capacity of the posterior cerebral circulation and unimpaired systemic endothelial function
in migraine patients without comorbidities. However, the relationship between cerebral and systemic endothelial
function and the anterior and posterior cerebral endothelial function in migraine patients is still not clear.
Methods: We compared cerebral and systemic endothelial function through post-hoc linear regression analysis of
cerebrovascular reactivity (CVR) to L-arginine between the middle cerebral artery (MCA) and flow-mediated
vasodilatation (FMD) of the right brachial artery and the posterior cerebral artery (PCA) and FMD in migraine
patients without comorbidities and in healthy subjects. The anterior and posterior cerebral endothelial function was
also compared using post-hoc linear regression analysis between CVR to L-arginine in the MCA and the PCA.
Results: No significant correlation was found between CVR to L-arginine in the MCA and FMD and in the PCA and
FMD in migraine patients with aura (p = 0.880 vs. p = 0.682), without aura (p = 0.153 vs. p = 0.179) and in healthy
subjects (p = 0.869 vs. p = 0.662). On the other hand, we found a significant correlation between CVR to L-arginine
in the MCA and PCA in migraine patients with aura (p = 0.004), without aura (p = 0.001) and in healthy subjects (p
= 0.002). Detailed analysis of the linear regression between all migraine patients and healthy subjects did not show
any difference in the regression coefficient (slope) (p = 0.382). However, a significant difference in curve elevation
(intercept) was found (p = 0.002).
Conclusions: Our study suggests that the endothelial function in the cerebral and systemic circulation might be
different in migraine patients without comorbidities, while that of the anterior and posterior cerebral circulation
might be coupled. These results could improve understanding of endothelial function in migraine patients without
comorbidities.
Background
In recent years it has been proposed that migraine
patients have endothelial dysfunction [1]. However, both
our group and that of Vanmolkot have found unim-
paired systemic endothelial function in migraine patients
without comorbidities [2,3]. Instead, we have shown that
endothelial dysfunction in migraine patients without
comorbidities could be limited to the posterior cerebral
circulation [4]. Vanmolkot et al. also referred to the lack
of studies comparing cerebral and systemic endothelial
function in the same patients [3]. Therefore, it is still
unclear whether there is an association between cerebral
and systemic endothelial function in migraine patients.
The only study comparing cerebral and systemic
endothelial function simultaneously is that of Pretnar-
Oblak et al., who concluded that cerebral and systemic
endothelial function might not be closely associated in
patients with lacunar infarctions [5]. However, this
study compared endothelial function in the anterior cer-
ebral and systemic circulation. No study comparing the
posterior cerebral and systemic endothelial function has
yet been undertaken.
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to higher endothelial function in the posterior cerebral
circulation compared to that in the anterior circulation
in healthy subjects [6]. Despite this finding, and the fact
that migraine patients might have endothelial dysfunc-
tion in the posterior cerebral circulation, it is still
unclear whether the endothelial function in the poster-
ior and middle cerebral artery territories is associated in
migraine patients.
In our previous studies, the methods of cerebrovascu-
lar reactivity (CVR) to L-arginine and flow- mediated
vasodilatation (FMD) were used to assess the anterior
and posterior cerebral and systemic endothelial function
[7-14]. We also measured carotid intima-media thick-
ness (IMT) obtained the medical history and performed
physical and neurological examinations, and routine
laboratory tests. With inclusion criteria of normal values
of IMT and exclusion of vascular risk factors, only
migraine patients without comorbidities and healthy
subjects without known underlying vascular disease or
risk factors were included in these studies.
The aims of our study were as follows: I) to compare
endothelial function in the anterior and posterior cere-
bral circulation with the systemic endothelial function in
migraine patients without comorbidities; II) to compare
the endothelial function in the anterior and posterior
cerebral circulation in migraine patients without
comorbidities.
Although these comparisons have not yet been per-
formed, this knowledge could be important for under-
standing the endothelial role of different vascular beds
in migraine patients without comorbidities.
Methods
This post-hoc study was performed using data obtained
from previous studies with the primary aim of compar-
ing endothelial function in the anterior and posterior
cerebral with the systemic endothelial function and the
secondary aim of comparing endothelial function in the
anterior and posterior cerebral circulation in migraine
patients without comorbidities. Forty migraine patients
and twenty healthy subjects participated in two previous
studies, which were approved by the National Medical
Ethics Committee of the Republic of Slovenia. All sub-
jects gave written informed consent before being
included in the study. Migraine patients were diagnosed
according to the International Headache Society criteria
(2
nd edition) [15]. Healthy subjects were randomly
recruited from hospital staff and acquaintances after
completion of a questionnaire. Migraine patients were
randomly recruited from a headache clinic. All subjects
had a normal somatic and neurological examination.
Migraine patients were divided into two groups, 20
patients with migraine with aura (MwA) and 20 patients
without aura (MwoA). The median monthly headache
attack frequency in migraine patients was 2.0 ± 1.1. The
three groups were matched for gender (4 males and 16
females in each group) and age (healthy 33.4 ± 7.5
years, MwA 34.1 ± 8.3 years, MwoA 34.3 ± 7.7 years).
None of the subjects in the control group was suffering
from headache when the study was conducted and none
had migraine or other headache. Migraine patients had
the last migraine episode more than 24 hours before the
investigations were conducted.
The major exclusion criteria were: history of cardio-
vascular disease, arterial hypertension (systolic blood
pressure (SBP) > 140 mm Hg or diastolic blood pressure
(DBP) > 90 mmHg), body mass index (BMI) < 18 and ≥
25 kg/m
2, hypercholesterolaemia (total cholesterol > 5.5
mmol/L), diabetes, IMT > 1.0 mm, pregnancy or lacta-
tion and regular use of vasoactive drugs (except triptane
or other transient vasoactive antimigraine drugs).
Colour-coded duplex sonography of the carotid and
vertebral arteries was performed in all patients. IMT
was measured according to the Mannheim Intima-
Media Thickness Consensus on both sides 2 cm below
the bifurcation on the far wall of the common carotid
artery [16]. The distance between the characteristic
echoes from the lumen-intima and media-adventitia
interfaces was measured. The final IMT value was based
on the mean value of three maximal IMT measure-
ments. Subjects with plaques (focal structures that
encroached into the arterial lumen of at least 0.5 mm or
50% of the surrounding IMT value or demonstrated a
thickness > 1.5 mm) were excluded from the study.
FMD of the right brachial artery was performed
according to the recommendations of Corretti et al. in a
quiet room under constant conditions between 7.30 and
10.30 am after a fasting period of at least 10 hours [17].
A high-resolution ultrasound system with a 10-MHz lin-
ear array transducer located 2 to 10 cm above the ante-
cubital fossa was used. The brachial artery was scanned
in the longitudinal section, and the end-diastolic mean
arterial diameter was measured at the end of the dia-
stole period, incident with the R-wave on the simulta-
neously recorded electrocardiogram. A hyperaemic flow
increase was then induced by inflation of a blood pres-
sure cuff to a pressure of 50 mm Hg higher than the
measured systolic blood pressure for 4 minutes. The
hyperaemic diameter was recorded within 1 minute
after cuff deflation and the final scan was performed 4
minutes later. FMD was expressed as the percentage
change in the artery diameter after reactive hyperaemia
relative to the baseline scan.
CVR to L-arginine was simultaneously measured in
the anterior and posterior cerebral circulation. For this
purpose the middle (MCA) and the posterior cerebral
artery (PCA) were chosen. The experiment consisted of
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infusion of 100 mL 30% L-arginine, and a 10-minute
period after L-arginine application. The mean arterial
velocity (vm) in the MCA was recorded through the left
temporal acoustic window at a depth of 50 to 60 mm,
and in the PCA through the right temporal acoustic
window at a depth of 50 to 60 mm, with a mechanical
probe holder maintaining a constant probe position.
TCD Multi-Dop X4 software was used to determine vm
during the 5-minute baseline period and the 5-minute
period after L-arginine infusion. CVR to L-arginine in
the PCA and the MCA was expressed as the percentage
change in the vm after stimulation with L-arginine.
The variables FMD and CVR were statistically ana-
lysed by the statistic software SPSS 18.0 and GraphPad.
For this purpose linear regression analysis was used to
analyse possible correlations between the variables of
FMD and CVR in each of the groups: all migraine
patients, with aura, without aura, and healthy subjects.
In addition, linear regression analysis was used to test
the significance of the regression coefficients and curve
elevations between migraine patients (all, with aura,
without aura) and healthy subjects.
Results
All subjects had normal values of SBP, DBP, BMI, total
cholesterol, HDL, LDL, triglycerides, IMT, and glucose
(Table 1) [4].
First, we analysed the correlation between FMD and
CVR to L-arginine. We did not find any significant cor-
relation between FMD and CVR to L-arginine in the
MCA (p = 0.287; r
2 = 0.031; Figure 1) and between
FMD and CVR to L-arginine in the PCA (p = 0.582; r
2
= 0.008; Figure 2) in all migraine patients. Similarly, we
did not find any significant correlation between FMD
and CVR to L-arginine in the MCA in MwA (p = 0.880;
r
2 =0 . 0 0 1 )a n dM w o A( p=0 . 1 5 3 ;r
2 = 0.117), or
between FMD and CVR to L-arginine in the PCA in
MwA (p = 0.682; r
2 = 0.010) and MwoA (p = 0.179; r
2
= 0.104), nor did we find any significant correlation
between FMD and CVR to L-arginine in the MCA (p =
0.869; r
2 = 0.002) and FMD and CVR to L-arginine in
the PCA (p = 0.662; r
2 = 0.011) in healthy subjects.
In the next step we analysed the correlation between
CVR to L-arginine in the PCA and the MCA. We found
a significant positive correlation between CVR to L-argi-
nine in the PCA and the MCA in all migraine patients
Table 1 Biochemical and morphological parameters of
healthy subjects, MwA and MwoA
Healthy MwA MwoA
Total cholesterol (mmol/L) 4.79 ± 0.74 4.68 ± 0.68 4.41 ± 0.87
HDL cholesterol (mmol/L) 1.65 ± 0.36 1.64 ± 0.30 1.61 ± 0.33
LDL cholesterol (mmol/L) 2.79 ± 0.52 2.67 ± 0.72 2.35 ± 0.76
Triglycerides (mmol/L) 0.79 ± 0.34 0.89 ± 0.35 0.82 ± 0.23
Serum glucose (mmol/L) 4.97 ± 0.50 4.66 ± 0.35 4.73 ± 0.49
SBP (mmHg) 115.3 ± 7.9 116.2 ± 10.5 118.9 ± 11.8
DBP (mmHg) 77.0 ± 6.6 77.6 ± 5.6 79.2 ± 6.9
BMI (kg/m
2) 20.8 ± 1.5 21.3 ± 2.3 22.2 ± 2.6
IMT (mm) 0.39 ± 0.07 0.39 ± 0.07 0.40 ± 0.06
MwA = migraine with aura, MwoA = migraine without aura, SBP = systolic
blood pressure, DBP = diastolic blood pressure, BMI = body mass index, IMT =
intima-media thickness
Figure 1 Scatter plot of comparison between CVR to L-arginine
in the PCA and FMD. Scatter plot of comparison between
cerebrovascular reactivity (CVR) to L-arginine in the posterior
cerebral artery (PCA) and brachial artery flow-mediated dilation
(FMD) in migraine patients with and without aura (p = 0.582; r
2 =
0.008).
Figure 2 Scatter plot of comparison between CVR to L-arginine
in the MCA and FMD. Scatter plot of comparison between
cerebrovascular reactivity (CVR) to L-arginine in the middle cerebral
artery (MCA) and brachial artery flow-mediated dilation (FMD) in
migraine patients with and without aura (p = 0.287; r
2 = 0.031).
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2 = 0.377; Figure 3), MwA (p = 0.008; r
2 =
0.333), MwoA (p = 0.001; r
2 =0 . 4 4 1 )a n di nh e a l t h y
subjects (p = 0.001; r
2 =0 . 4 8 1 ) ,b u tw ed i dn o tf i n da n y
significant difference in regression coefficients (b)
between all migraine patients (b = 0.642) and healthy
subjects (b = 0.866) (p = 0.382), MwA (b = 0.584) and
healthy subjects (p = 0.342) and MwoA (b = 0.725) and
healthy subjects (p = 0.624). However, we found a sig-
nificantly higher rate of curve elevation (intercept) in
the group of healthy subjects compared to that in the
group of all migraine patients (p = 0.002), MwA (p =
0.01) and MwoA (p = 0.007).
Discussion
The main and original finding of our post-hoc study is
that we did not find any correlation between CVR to L-
arginine in the anterior and posterior cerebral circula-
tion and FMD in migraine patients without comorbid-
ities and healthy subjects. In other words, our results
showed that endothelial function in the cerebral circula-
tion probably differs from that in the systemic circula-
tion under physiological conditions as well as in
neurovascular disorders such as migraine.
There are almost no studies comparing cerebral and
systemic endothelial function. To the best of our knowl-
edge, the only study to perform such a comparison is
that of Pretnar-Oblak et al., who reported an absence of
any association between CVR to L-arginine in MCA and
FMD in patients with lacunar infarctions [5]. However,
they did not compare CVR to L-arginine in the PCA
and FMD, and their patients obviously had vascular risk
factors, which altered endothelial function in the
cerebral and systemic circulation. It is important to
highlight the supposition that migraine is a systemic
vascular disorder. Several studies have shown that
migraine is associated not only with cerebrovascular
events, but also with disorders of the coronary, retinal
and peripheral vasculature [1]. However, in many stu-
dies the authors did not exclude vascular risk factors, or
perhaps they excluded many vascular risk factors but
did not evaluate IMT, a morphological marker of the
early atherosclerotic process and associated endothelial
dysfunction, which consequently might have biased their
findings [18-23]. Nevertheless, the results of our study
and that of Pretnar-Oblak et al. are in accordance with
the supposition that endothelial function is not uniform
throughout the arterial system. This difference could be
present between organs and different vascular beds
within the same organ, even in the absence of diseases
known to affect endothelial function [24-26]. Further-
more, the belief that atherosclerosis is the main patho-
physiological process in coronary disease - and to lesser
extent in cerebrovascular diseases - might also reflect
this fact.
It must be emphasized that cerebral endothelial func-
tion in healthy subjects or in patients with endothelial
dysfunction cannot be predicted on the basis of evalua-
tion of the systemic endothelial function. Only by simul-
taneous comparison of both endothelial functions can
we evaluate the association between the cerebral and
systemic circulation. Since studies have shown differ-
ences in endothelial function between organs, one might
expect these differences also to exist between the cere-
bral and systemic circulation in healthy subjects. How-
ever, this may not apply to patients with endothelial
dysfunction of the cerebral and systemic circulation. For
this reason we evaluated endothelial function only in
migraine patients without comorbidities.
Linear regression analysis of CVR to L-arginine
between the MCA and the PCA showed positive corre-
lations in healthy subjects and migraine patients with
and without aura, without any significant differences in
regression coefficients (slopes) between healthy controls
and migraine patients (Figure 2). These results could
suggest a coupling of the endothelial function in the
anterior and posterior cerebral circulation in both
healthy subjects and migraine patients. Indeed, the
whole brain must be supplied with blood, regardless of
which parts needs a higher blood flow. The anterior and
posterior cerebral circulation is anatomically coupled by
the circle of Willis. However, the physiological factors
involved in the coupling are largely unknown. The
results of animal studies suggest that the endothelium in
the anterior and posterior circulation responds differ-
ently to the precursor of nitric oxide (NO) and inhibi-
tors of NO synthetase (NOS) and that the posterior
Figure 3 C o r r e l a t i o nb e t w e e nC V Rt oL - a r g i n i n ei nt h eM C A
and the PCA. Correlation between cerebrovascular reactivity (CVR)
to L-arginine in the middle cerebral artery (MCA) and the posterior
cerebral artery (PCA) in all migraine patients (p < 0.001; r
2 = 0.377)
and healthy subjects (p = 0.001; r
2 = 0.481).
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control to NO than the anterior cerebral circulation
[27-29]. In addition, our previous study showed the pos-
sibility that the endothelium of the posterior cerebral
circulation has a higher vasodilatatory capacity com-
pared to the anterior cerebral circulation [6].
Nevertheless, the regulation of regional blood flow in
the territory of the posterior cerebral artery is probably
altered in migraine patients [4]. This assumption has
again been shown by a significant difference in curve
elevation (intercept) between migraine patients and
healthy controls (Figure 3). Therefore, it could be specu-
lated that migraine patients have reduced vasodilatatory
capacity in the posterior cerebral circulation. Despite
this finding, our present study implies endothelial cou-
pling between the anterior and posterior cerebral circu-
lation, not only in healthy subjects but also in migraine
patients.
Our study has some limitations. The study population
was relatively small; hence our conclusions must be
treated with some caution. The methods, FMD and
CVR to L-arginine, have some limitations and they
probably reflect different aspects of induced vasoreactiv-
ity, hence they cannot be simply compared. The hyper-
capnic response before and after L-arginine infusion
could further improve understanding of cerebral
endothelial function [30]. However, the mechanisms of
CO2-produced vasodilatation are not entirely known,
and CO2-induced vasodilatation is only partially related
to NO-dependent mechanisms [31]. Since the aims of
this and our previous studies were to evaluate and com-
pare endothelium-dependent vasodilatation of the cere-
bral and systemic circulation in migraine patients, we
did not evaluate endothelium-independent vasodilatation
of the brachial artery. We believe that this would not
give additional information about the role of the
endothelium in vasoreactivity. Another limitation is that,
with the exclusion of migraine patients with thickened
IMT, we did not take into account the possibility that
migraine itself might induce thickening of IMT and con-
sequently impair vasoreactivity. However, we believe
that this explanation is less likely. It must also be
emphasized that evaluating endothelial function involves
not only evaluating vasoreactivity but also the inflamma-
tory and coagulatory milieu [32,33]. However, the tests
of both milieus are nonspecific.
The results of this study are different from those
obtained in our previous studies since neither the eva-
luation of the relationship between FMD and CVR to L-
arginine in the PCA and the MCA nor the evaluation of
the relationship between CVR to L-arginine in the PCA
and the MCA have been performed in our previous stu-
dies or in any other study in which migraine patients
were included [2,4,6].
Considering all these findings, it would be interesting
to discover whether evaluation of the cerebral endothe-
lial function in migraine patients could be useful in
identifying migraine patients at higher risk of experien-
cing ischaemic cerebral events.
Conclusion
Taking into account the presented analysis and our pre-
vious results, the following can be concluded in
migraine patients without comorbidities: I) the cerebral
a n ds y s t e m i cc i r c u l a t i o n sp r o b a b l yh a v ed i f f e r e n t
endothelial functions; II) endothelial function in the
anterior and posterior cerebral circulation might be
coupled.
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